AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_54_Risk of residual transmission of hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) through blood transfusion in Burkina Faso: preliminary resultsView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_53_Prevalence of Hepatitis among Select Key Populations in Botswana – Results of the 2nd Biological and Behavioral Surveillance SurveyView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_52_Rwanda’s journey to achieve low prices for Hepatitis C treatment drugsView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_51_Hepatitis C Elimination in Rwanda: The Case-Finding JourneyView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_50_Hepatorenal Modulatory Effects of Ricinus Communis fractions in Acetaminophen-induced Hepatic-nephrotoxicity in Murine ModelView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_49_Les hépatites auto-immunes à l’Hôpital Principal de Dakar : étude rétrospective à propos de 19 cas.View Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_48_IL-23 and MMP-9 as predictors of adverse course of psoriasis and NAFLD comorbiditiesView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_47_Impact of Treating Hyperuricemic NAFLD Patients with Allopurinol on Cytokeratin 18: A Pilot StudyView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_46_Correction of portohepatic hemodynamics disorders and increased ammonia by ornithine at the non-alcoholic steatohepatitis patients without cirrhosisView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_45_Devenir au long cours des patients traités par analogues nucléot(s)idiques pour cirrhose virale B à l’Hôpital Principal de DakarView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_44_Clinical and laboratory predictors of mortality in patients hospitalized for liver cirrhosis in CameroonView Abstract
AbstractViral Hepatitis and Liver DiseaseConference on Liver Disease in Africa (COLDA) 2020COLDA_2020_abstract_43_Plasminogen Activator Inhibitor Type 1 in Liver Cirrhosis Patients and Non-Alcoholic Steatohepatitis under the Influence of Treatment with Human Albumin InfusionView Abstract
